Intranet
Yousra Kherabi | IAME
Yousra Kherabi Position: Contract researcher / CCA Affiliation: UPCité
Team: PREVIST

Publications

Machine learning to predict antimicrobial resistance: future applications in clinical practice?

2024

DOI

PubMed

Copy reference

Infectious Diseases Now

Kherabi Y et al.Kherabi Y, Thy M, Bouzid D, Antcliffe DB, Rawson TM, Peiffer-Smadja N

Epidemiology, treatment and outcomes of infected pancreatic necrosis in France: a bicenter study.

2024

DOI

PubMed

Copy reference

Infectious diseases now

Kherabi Y et al.Kherabi Y, Michoud C, Villageois-Tran K, Bert F, Pioche M, Lefort A, Lévy P, Rebours V, Zarrouk V

Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas

2023

DOI

PubMed

Copy reference

Cancers

Pilmis B et al.Pilmis B, Kherabi Y, Huriez P, Zahar JR, Mokart D

A recurrent pleuropneumonia revealing Erdheim-Chester Disease

2023

DOI

PubMed

Copy reference

Respiratory Medicine Case Reports

Kherabi Y et al.Kherabi Y, Chazal T, Emile JF, Allaham W, Mallart E, de Lastours V, Haroche J, Nguyen Y

Machine learning, antimicrobial stewardship, and solid organ transplantation: Is this the future?

2022

DOI

PubMed

Copy reference

Transplant Infectious Disease: An Official Journal of the Transplantation Society

Kherabi Y et al.Kherabi Y, Messika J, Peiffer-Smadja N

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019

2022

DOI

PubMed

Copy reference

Emerging Infectious Diseases

Kherabi Y et al.Kherabi Y, Fréchet-Jachym M, Rioux C, Yazdanpanah Y, Méchaï F, Pourcher V, Robert J, Guglielmetti L, MDR-TB Management Group

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review

2022

DOI

PubMed

Copy reference

Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases

Fiolet T et al.Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N

Efficacy and safety of efavirenz, raltegravir and dolutegravir in HIV-1/TB co-infection. A multicenter retrospective cohort study in France

2022

DOI

PubMed

Copy reference

Journal of Acquired Immune Deficiency Syndromes (1999)

Kherabi Y et al.Kherabi Y, de Castro N, Sellier PO, Hamet G, Brun A, Méchaï F, Joly V, Yazdanpanah Y, Molina JM

Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we?

2022

DOI

PubMed

Copy reference

PLOS global public health

Kherabi Y et al.Kherabi Y, Mollo B, Gerard S, Lescure FX, Rioux C, Yazdanpanah Y

Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19

2020

DOI

PubMed

Copy reference

The Journal of Infection

Garrigues E et al.Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, Corre F, Zarrouk V, Moyer JD, Galy A, Honsel V, Fantin B, Nguyen Y

[Gynecological Lemierre's syndrome: A case report and literature review]

2020

DOI

PubMed

Copy reference

La Revue De Medecine Interne

Kherabi Y et al.Kherabi Y, Chevrel G, Roux D, Federici L